Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; the references it cites are not checked yet.

β-Amyloid precursor protein transgenic mice that harbor diffuse Aβ deposits but do not form plaques show increased ischemic vulnerability: Role of inflammation

Open access
Koistinaho, Milla, Kettunen, Mikko I., Goldsteins, Gundars, Keinänen, Riitta, Salminen, Antero, Ort, Michael, Bures, Jan, Liu, David, Kauppinen, Risto A., Higgins, Linda S., Koistinaho, Jari · 2002 · Proceedings of the National Academy of Sciences

Abstract

β-amyloid (Aβ), derived form the β-amyloid precursor protein (APP), is important for the pathogenesis of Alzheimer's disease (AD), which is characterized by progressive decline of cognitive functions, formation of Aβ plaques and neurofibrillary tangles, and loss of neurons. However, introducing a human wild-type or mutant APP gene to rodent models of AD does not result in clear neurodegeneration, suggesting that contributory factors lowering the threshold of neuronal death may be present in AD. Because brain ischemia has recently been recognized to contribute to the pathogenesis of AD, we studied the effect of focal brain ischemia in 8- and 20-month-old mice overexpressing the 751-amino acid isoform of human APP. We found that APP751 mice have higher activity of p38 mitogen-activated protein kinase (p38 MAPK) in microglia, the main immune effector cells within the brain, and increased vulnerability to brain ischemia when compared with age-matched wild-type mice. These characteristics are associated with enhanced microglial activation and inflammation but not with altered regulation of cerebral blood flow, as assessed by MRI and laser Doppler flowmetry. Suppression of inflammation with aspirin or inhibition of p38 MAPK with a selective inhibitor, SD-282, abolishes the increased neuronal vulnerability in APP751 transgenic mice. SD-282 also suppresses the expression of inducible nitric-oxide synthase and the binding activity of activator protein 1. These findings elucidate molecular mechanisms of neuronal injury in AD and suggest that antiinflammatory compounds preventing activation of p38 MAPK in microglia may reduce neuronal vulnerability in AD.

Overview

Integrity signals

Registry

Crossref · 10.1073/pnas.032670899

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists are queued

They are fetched later and appear here then.

References 55 · Cited by 159

Research works printed but not linked: 2

  1. F W van Leeuwen, E M Hol J Neural Transm Suppl 57, 137–159 (1999).
  2. F C Barone, E A Irving, A M Ray, J C Lee, S Kassis, S Kumar, A M Badger, R F White, M J McVey, J J Legos, et al. J Pharmacol Exp Ther 296, 312–321 (2001).

Metadata

Authors
Koistinaho, M., Kettunen, M. I., Goldsteins, G., Keinänen, R., Salminen, A., Ort, M., Bures, J., Liu, D., Kauppinen, R. A., Higgins, L. S., & Koistinaho, J.
Affiliations
  • Czech Academy of Sciences (CZ)
  • A.I. Virtanen Institute for Molecular Sciences, Department of Neurology and Neuroscience, Department of Clinical Pathology of Kuopio University Hospital, University of Kuopio, P.O. Box 1627, FIN-70211, Kuopio, Finland; Institute of Physiology, Academy of Sciences of the Czech Republic, Videnska 1083, 142 20 Prague 4-Krc, Czech Republic; Department of Psychiatry, First School of Medicine, Charles University, Ke Karlovu 11, 128 08 Prague 2, Czech Republic; and Scios Incorporated, Sunnyvale, CA 94085
Venue
Proceedings of the National Academy of Sciences
Published
2002-01-29
Volume
99
Issue
3
Pages
1610-1615
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2085431369
Cited by
159
References
55
Citations by year
2026: 1 · 2024: 1 · 2023: 1 · 2022: 4 · 2021: 4 · 2020: 6 · 2019: 3 · 2018: 2 · 2017: 5 · 2016: 10 · 2015: 4 · 2014: 10 · 2013: 10 · 2012: 9
FWCI
7.99
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords
amyloid precursor protein, Alzheimer's disease, focal cerebral ischemia, ischemic vulnerability, microglial activation, neuroinflammation, p38 MAPK, aspirin, inducible nitric oxide synthase, activator protein-1, cerebral blood flow, neuronal injury
MeSH terms
MAP-Kinase-Activated Kinase 2, Alzheimer Disease, Animals, Aspirin, Blood Pressure, Brain, Carbon Dioxide, Brain Ischemia, Enzyme Inhibitors, Humans, Indoles, Inflammation, Magnetic Resonance Imaging, Mice, Transgenic, Oxygen, Partial Pressure, Amyloid beta-Protein Precursor, Protein Serine-Threonine Kinases, Microglia, Transcription Factor AP-1, Reverse Transcriptase Polymerase Chain Reaction, Mitogen-Activated Protein Kinases, Intracellular Signaling Peptides and Proteins, p38 Mitogen-Activated Protein Kinases, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: β-Amyloid precursor protein transgenic mice that harbor diffuse Aβ deposits but do not form plaques show increased ischemic vulnerability: Role of inflammation. https://app.cochat.ai/papers/10.1073/pnas.032670899
The paper
Koistinaho, M., Kettunen, M. I., Goldsteins, G., Keinänen, R., Salminen, A., Ort, M., Bures, J., Liu, D., Kauppinen, R. A., Higgins, L. S., & Koistinaho, J. (2002). β-Amyloid precursor protein transgenic mice that harbor diffuse Aβ deposits but do not form plaques show increased ischemic vulnerability: Role of inflammation. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.032670899

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.